These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24138924)

  • 1. Endocannabinoids promote cocaine-induced impulsivity and its rapid dopaminergic correlates.
    Hernandez G; Oleson EB; Gentry RN; Abbas Z; Bernstein DL; Arvanitogiannis A; Cheer JF
    Biol Psychiatry; 2014 Mar; 75(6):487-98. PubMed ID: 24138924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice.
    Mereu M; Tronci V; Chun LE; Thomas AM; Green JL; Katz JL; Tanda G
    Addict Biol; 2015 Jan; 20(1):91-103. PubMed ID: 23910902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-induced dopamine terminal deficits in the nucleus accumbens are exacerbated by reward-associated cues and attenuated by CB1 receptor antagonism.
    Loewinger GC; Beckert MV; Tejeda HA; Cheer JF
    Neuropharmacology; 2012 Jun; 62(7):2192-201. PubMed ID: 22306525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous dopamine and endocannabinoid signaling mediate cocaine-induced reversal of AMPAR synaptic potentiation in the nucleus accumbens shell.
    Ingebretson AE; Hearing MC; Huffington ED; Thomas MJ
    Neuropharmacology; 2018 Mar; 131():154-165. PubMed ID: 29225042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposing roles of CB
    Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
    Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
    Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
    Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impulsive Rats Exhibit Blunted Dopamine Release Dynamics during a Delay Discounting Task Independent of Cocaine History.
    Moschak TM; Carelli RM
    eNeuro; 2017; 4(2):. PubMed ID: 28451642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids mediate long-lasting behavioural and physiological changes in male rats induced by the repeated activation of the mesolimbic system by copulation to satiety.
    Rodríguez-Manzo G; González-Morales E
    Behav Brain Res; 2020 Apr; 383():112510. PubMed ID: 31987931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of basolateral amygdala dopamine D2 receptors in impulsive choice in acute cocaine-treated rats.
    Li Y; Zuo Y; Yu P; Ping X; Cui C
    Behav Brain Res; 2015; 287():187-95. PubMed ID: 25823760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cocaine-induced increases in motivation require 2-arachidonoylglycerol mobilization and CB1 receptor activation in the ventral tegmental area.
    Engi SA; Beebe EJ; Ayvazian VM; Cruz FC; Cheer JF; Wenzel JM; Zlebnik NE
    Neuropharmacology; 2021 Aug; 193():108625. PubMed ID: 34058192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice.
    Li X; Hoffman AF; Peng XQ; Lupica CR; Gardner EL; Xi ZX
    Psychopharmacology (Berl); 2009 May; 204(1):1-11. PubMed ID: 19099297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta.
    Freestone PS; Guatteo E; Piscitelli F; di Marzo V; Lipski J; Mercuri NB
    Neuropharmacology; 2014 Apr; 79():467-75. PubMed ID: 24334069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats.
    Hernandez G; Cheer JF
    J Neurosci; 2012 Aug; 32(33):11467-77. PubMed ID: 22895729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine elevates nucleus accumbens dopamine via an action potential-dependent mechanism that is modulated by endocannabinoids.
    Covey DP; Bunner KD; Schuweiler DR; Cheer JF; Garris PA
    Eur J Neurosci; 2016 Jun; 43(12):1661-73. PubMed ID: 27038339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
    Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitization to cocaine is inhibited after intra-accumbal GR103691 or rimonabant, but it is enhanced after co-infusion indicating functional interaction between accumbens D(3) and CB1 receptors.
    Ramiro-Fuentes S; Fernandez-Espejo E
    Psychopharmacology (Berl); 2011 Apr; 214(4):949-59. PubMed ID: 21128069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel MAGL inhibitor MJN110 enhances responding to reward-predictive incentive cues by activation of CB1 receptors.
    Feja M; Leigh MPK; Baindur AN; McGraw JJ; Wakabayashi KT; Cravatt BF; Bass CE
    Neuropharmacology; 2020 Jan; 162():107814. PubMed ID: 31628934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
    Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
    Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bi-directional cannabinoid signalling in the basolateral amygdala controls rewarding and aversive emotional processing via functional regulation of the nucleus accumbens.
    Ahmad T; Sun N; Lyons D; Laviolette SR
    Addict Biol; 2017 Sep; 22(5):1218-1231. PubMed ID: 27230434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.